Theeffects of PPARα ligands in animal models of tumorangiogenesis should help not only to stimulate further research of theirusefulness as antitumorigenic agents, but also to facilitate their evaluationas valid tools for the treatment and/or prevention of human cancers. This evidence concerns the gene PPARA and cancer.